Clinical Trial Update: A Randomized, Controlled, Comparative Study of a Levonorgestrel Intrauterine System for the Prevention of Endometrial Cancer in Patients Aged 40-50 With BMI Greater Than 35

View source ↗

Summary

A randomized, controlled trial evaluating a levonorgestrel intrauterine system for preventing endometrial cancer in women aged 40-50 with BMI over 35 was termin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Levonorgestrel intrauterine system (levonorgestrel intrauterine system)

Snippet

Sponsor: University of Medicine and Dentistry of New Jersey | Conditions: Endometrial Cancer | Status: TERMINATED